Allergan defense vs. Valeant/Pershing Square

A company’s own rebuttal deck, built on advisor analysis, arguing a hostile bid line by line rather than in a courtroom.

Goldman Sachs · Bank of America Merrill Lynch · 2014 · $53B · 12 slides · DEFA14A exhibit

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  1. Slide 1 of 12
  2. Slide 2 of 12
  3. Slide 3 of 12
  4. Slide 4 of 12
  5. Slide 5 of 12
  6. Slide 6 of 12
  7. Slide 7 of 12
  8. Slide 8 of 12
  9. Slide 9 of 12
  10. Slide 10 of 12
  11. Slide 11 of 12
  12. Slide 12 of 12

Join the free newsletter

A free weekly email on breaking into banking and building your career in finance. Read by 30,000+ people.